Caricamento...
Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness
Genetic variants account for approximately half the cases of congenital and early‐onset deafness. Methods and technologies for viral delivery of genes into the inner ear have evolved over the past decade to render gene therapy a viable and attractive approach for treatment. Variants in SYNE4, encodi...
Salvato in:
| Pubblicato in: | EMBO Mol Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863404/ https://ncbi.nlm.nih.gov/pubmed/33350593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013259 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|